Home › Funds › Column Group LLC › SRZN
Column Group LLC position in SRZN
SURROZEN INC · Health Care
Column Group LLC reported holding 1,916,950 shares of SRZN (SURROZEN INC) in its Q2 2026 13F filing — a position valued at US$49.7M, representing 56.46% of its reported portfolio and ranking #1 among its reported holdings. Column Group LLC has disclosed SRZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Column Group LLC's SRZN position evolved
Column Group LLC first disclosed a stake in SRZN in Q3 2023 at 9,414,795 shares (US$4.6M). The position peaked in Q1 2026 at 1,916,950 shares, worth US$55.8M. Across 12 filings, Column Group LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 1,916,950 shares valued at US$49.7M. Notable position changes include a 93% trim in Q4 2023 (shares rose 67% over the following quarter), a 31% increase in Q2 2024 (shares rose 9% over the following quarter), a 85% increase in Q1 2025 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 9.41M | $4.61M | New |
| Q4 2023 | 627.65K | $5.90M | Reduce |
| Q1 2024 | 616.54K | $9.69M | Reduce |
| Q2 2024 | 810.09K | $8.87M | Add |
| Q3 2024 | 810.09K | $9.70M | Hold |
| Q4 2024 | 810.09K | $11.62M | Hold |
| Q1 2025 | 1.50M | $17.49M | Add |
| Q2 2025 | 1.50M | $13.41M | Hold |
| Q3 2025 | 1.50M | $19.33M | Hold |
| Q4 2025 | 1.85M | $41.84M | Add |
| Q1 2026 | 1.92M | $55.84M | Add |
| Q2 2026 | 1.92M | $49.74M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRZN and 13F data
SRZN (SURROZEN INC) is a Health Care company. 51 other funds we track also report a position in SRZN — the largest reported positions include TCG Crossover Management, LLC (US$38.2M), Boxer Capital Management, LLC (US$27.0M), Venrock Adviser, LLC (US$16.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRZN
- TCG Crossover Management, LLC 1.47M sh · $38.23M · Q2 2026
- Boxer Capital Management, LLC 1.11M sh · $26.96M · Q2 2026
- Venrock Adviser, LLC 632.93K sh · $16.42M · Q2 2026
- STEMPOINT CAPITAL LP 602.80K sh · $13.79M · Q2 2026
- Spruce Street Capital LP 432.04K sh · $11.21M · Q2 2026
- Kalehua Capital Management LLC 385.18K sh · $10.00M · Q2 2026
- 5AM Venture Management, LLC 271.25K sh · $7.04M · Q2 2026
- Vivo Capital, LLC 260.00K sh · $6.75M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 173.40K sh · $4.50M · Q2 2026
- REGENTS OF THE UNIVERSITY OF CALIFORNIA 133.21K sh · $3.46M · Q2 2026
- Euclidean Capital LLC 87.70K sh · $2.28M · Q2 2026
More on Column Group LLC
FAQ
How long has Column Group LLC held SRZN?
Column Group LLC has disclosed SRZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Column Group LLC's current position in SRZN?
As of Q2 2026, Column Group LLC holds 1.92M shares of SRZN (SURROZEN INC), valued at $49.74M, representing 56.46% of its reported portfolio and ranking #1.
Has Column Group LLC been buying or selling SRZN?
In the latest 13F filing (Q2 2026), Column Group LLC held unchanged its position in SRZN. The position peaked in Q1 2026 at 1.92M shares.
Which other funds hold SRZN?
Other major institutional holders of SRZN include TCG Crossover Management, LLC, Boxer Capital Management, LLC, Venrock Adviser, LLC, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.